Clinical Trial: A Study of TAS3351 in NSCLC Patients With EGFRmt
Study Status: Completed
Recruit Status: RECRUITING
Condition: Non-Small Cell Lung Cancer
Study Type: INTERVENTIONAL
Official Title: A Phase 1/2 Study of TAS3351 in Patients With Advanced Non-Small Cell Lung Cancer and EGFR Mutations
Brief Summary:
This is a first-in-human, open label, Phase 1/2 study to investigate the safety and efficacy of TAS3351 in patients with advanced or metastatic non-small cell lung cancer (NSCLC) harboring an acquired C797S epidermal growth factor receptor (EGFR) mutation.
Read more